Use of Aborted Human Cell Lines in Vaccines Linked to Rise in Autism

Researchers from the Sound Choice Pharmaceutical Institute recently published a study showing a correlation with the introduction of human fetal cell lines used as contaminants in childhood vaccines, and the rapid rise of autism. The study was published in the Journal of Public Health and Epidemiology, an open access Academic Journal.

I reviewed the full length research paper and found the methodology of the research very thorough. The researchers tracked not only the introduction of aborted fetal cell lines introduced into vaccines used in the childhood vaccination scheduled in the United States, but they also tracked standards for autism diagnoses as published in the Diagnostic and Statistical Manual. This manual is used in the field of psychology and has undergone several revisions. One of the claims made for the rising rate of autism in America today is that it is primarily related to changes of diagnosis. This study used sophisticated software to account for these changes in autism diagnosis, and found:

“Autistic disorder change points years are coincident with introduction of vaccines manufactured using human fetal cell lines, containing fetal and retroviral contaminants, into childhood vaccine regimens. This pattern was repeated in the US, UK, Western Australia and Denmark. Thus, rising autistic disorder prevalence is directly related to vaccines manufactured utilizing human fetal cells. Increased paternal age and DSM revisions were not related to rising autistic disorder prevalence.”